Cargando…
Dimethyl Fumarate Triggers the Antioxidant Defense System in Human Retinal Endothelial Cells through Nrf2 Activation
Dimethyl fumarate (DMF) is a well-known activator of Nrf2 (NF-E2-related factor 2), used in the treatment of psoriasis and multiple sclerosis. The mechanism of action consists in the modification of the cysteine residues on the Nrf2-inhibitor Keap1, thus leading to the dissociation of these two prot...
Autores principales: | Manai, Federico, Amadio, Marialaura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598343/ https://www.ncbi.nlm.nih.gov/pubmed/36290650 http://dx.doi.org/10.3390/antiox11101924 |
Ejemplares similares
-
The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
por: Manai, Federico, et al.
Publicado: (2022) -
Novel potential pharmacological applications of dimethyl fumarate—an overview and update
por: Bresciani, Giorgia, et al.
Publicado: (2023) -
Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders
por: Manai, Federico, et al.
Publicado: (2023) -
Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
por: Scuderi, Sarah A., et al.
Publicado: (2020) -
Nature-Inspired Hybrids (NIH) Improve Proteostasis by Activating Nrf2-Mediated Protective Pathways in Retinal Pigment Epithelial Cells
por: Koskela, Ali, et al.
Publicado: (2022)